Implementation of an RIL-2/LAK cell clinical trial: a nursing perspective.
D002986:Clinical Trials as Topic; D006801:Humans; D007116:Immunization, Passive; D007376:Interleukin-2 / Q000009:adverse effects / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000276:immunology*; D008297:Male; D008545:Melanoma / Q000628:therapy*; D008875:Middle Aged; D009859:Oncology Nursing; D010347:Patient Care Planning; D011994:Recombinant Proteins / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000628:therapy*
D007376:Interleukin-2; D011994:Recombinant Proteins